CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
Kyu-Hyoung Lim, Ho-Il Yoon, Young Ae Kang, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jae Ho Lee, Choon-Taek Lee, Jong Seok Lee
Korean J Intern Med. 2010;25(1):86-92.   Published online 2010 February 26    DOI: https://doi.org/10.3904/kjim.2010.25.1.86

Excel Download

Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
The Korean Journal of Internal Medicine. 2010;25(1):86   Crossref logo
Link1 Link2 Link3

Rituximab plus Cyclophosphamide, Hydroxydaunomycin (Doxorubicin), Oncovin (Vincristine), and Prednisone (R-CHOP) Regimen for Non-Hodgkin's Lymphomas
Hospital Pharmacy. 2002;37(2):119-196   Crossref logo
Link1 Link2

Long-Term Results of Patients with Advanced Diffuse, Non-Hodgkin’s Lymphoma Treated with Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Bleomycin (CHOP-Bleo)
Oncology. 1983;40(3):186-191   Crossref logo
Link1 Link2

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
Yearbook of Oncology. 2007;2007:154-155   Crossref logo
Link1 Link2

Prognostic significance ofMYC,BCL2, andBCL6rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
Cancer. 2011;118(17):4173-4183   Crossref logo
Link1

Cyclophosphamide, Hydroxydaunomycin (Doxorubicin), Oncovin (Vincristine), and Prednisone (CHOP) Regimen for Advanced Non-Hodgkin's Lymphomas
Hospital Pharmacy. 2002;37(1):14-19   Crossref logo
Link1 Link2

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
OncoTargets and Therapy. 2016;3799   Crossref logo
Link1

Successful Treatment of Diffuse Large B-Cell Non-Hodgkin Lymphoma with Modified CHOP (Cyclophosphamide/Doxorubicin/Vincristine/ Prednisone) Chemotherapy and Rituximab in a Patient with Nijmegen Syndrome
Clinical Lymphoma and Myeloma. 2007;7(9):590-593   Crossref logo
Link1 Link2

Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine
Cancer. 2009;115(5):1041-1048   Crossref logo
Link1 Link2

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP)
Clinical Lymphoma Myeloma and Leukemia. 2014;14:S145-S146   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.